Can Dendritic Cell Vaccination Prevent Leukemia Relapse?

Leukemias are clonal proliferative disorders arising from immature leukocytes in the bone marrow. While the advent of targeted therapies has improved survival in certain subtypes, relapse after initial therapy is a major problem. Dendritic cell (DC) vaccination has the potential to induce tumor-spec...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, Liam J., Guillerey, Camille, Radford, Kristen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627518/
https://www.ncbi.nlm.nih.gov/pubmed/31234526
http://dx.doi.org/10.3390/cancers11060875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627518/
https://www.ncbi.nlm.nih.gov/pubmed/31234526
http://dx.doi.org/10.3390/cancers11060875

Ejemplares similares